Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer (Q27851456)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer
scientific article

    Statements

    Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer (English)
    Francesca Molinari
    0 references
    Piercarlo Saletti
    0 references
    Sara De Dosso
    0 references
    Luca Mazzucchelli
    0 references
    Milo Frattini
    0 references
    10 December 2008
    0 references
    26
    0 references
    35
    0 references
    5705-12
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit